Hide metadata

dc.date.accessioned2018-08-20T13:28:08Z
dc.date.available2018-08-20T13:28:08Z
dc.date.created2017-06-07T22:47:40Z
dc.date.issued2017
dc.identifier.citationWorkneh, Mahteme Haile Bjune, Gunnar Aksel Solomon, Abebe Yimer . Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS ONE. 2017, 12(4)
dc.identifier.urihttp://hdl.handle.net/10852/63251
dc.description.abstractIntroduction: The dual burden of tuberculosis (TB) and diabetes mellitus (DM) has become a major global public health concern. There is mounting evidence from different countries on the burden of TB and DM comorbidity. The objective of this systematic review was to summarize the existing evidence on prevalence and associated/risk factors of TBDM comorbidity at global and regional levels. Methods: Ovid Medline, Embase, Global health, Cochrane library, Web of science and Scopus Elsevier databases were searched to identify eligible articles for the systematic review. Data were extracted using standardized excel form and pilot tested. Median with interquartile range (IQR) was used to estimate prevalence of TBDM comorbidity. Associated/risk factors that were identified from individual studies were thematically analyzed and described. Results: The prevalence of DM among TB patients ranged from 1.9% to 45%. The overall median global prevalence was 16% (IQR 9.0%-25.3%) Similarly, the prevalence of TB among DM patients ranged from 0.38% to 14% and the overall median global prevalence was 4.1% (IQR 1.8%-6.2%). The highest prevalence of DM among TB patients is observed in the studied countries of Asia, North America and Oceania. On the contrary, the prevalence of TB among DM patients is low globally, but relatively higher in the studied countries of Asia and the African continents. Sex, older age, urban residence, tobacco smoking, sedentary lifestyle, poor glycemic control, having family history of DM and TB illness were among the variables identified as associated/risk factors for TBDM comorbidity. Conclusion: This systematic review revealed that there is a high burden of DM among TB patients at global level. On the contrary, the global prevalence of TB among DM patients is low. Assessing the magnitude and risk/associated factors of TBDM comorbidity at country/local level is crucial before making decisions to undertake TBDM integrated services.en_US
dc.languageEN
dc.publisherPublic Library of Science (PLoS)
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titlePrevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic reviewen_US
dc.typeJournal articleen_US
dc.creator.authorWorkneh, Mahteme Haile
dc.creator.authorBjune, Gunnar Aksel
dc.creator.authorSolomon, Abebe Yimer
cristin.unitcode185,52,0,0
cristin.unitnameInstitutt for helse og samfunn
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1474624
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS ONE&rft.volume=12&rft.spage=&rft.date=2017
dc.identifier.jtitlePLoS ONE
dc.identifier.volume12
dc.identifier.issue4
dc.identifier.pagecount25
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0175925
dc.identifier.urnURN:NBN:no-65807
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1932-6203
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/63251/2/Workneh_2017_Pre.pdf
dc.type.versionPublishedVersion
cristin.articleide0175925
dc.relation.projectNFR/NFR project# 234506


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International